Register to view the archived recording here.
Fluidigm Launches Higher-Throughput BioMark; Will Discontinue First-Gen System by Year End
The company said the new platform, the BioMark HD, will have twice the throughput as its predecessor, enabling faster time to result and allowing customers to more easily perform large-scale single-cell gene expression studies.
New to GenomeWeb? Register here quickly.